Patents by Inventor Syeda F.Y. HAQUE

Syeda F.Y. HAQUE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human anti-IFN-? antibodies
    Patent number: 11945861
    Abstract: Provided are novel IFB-a binding molecules of human origin, particularly human-derived anti-IFN-? antibodies as well as IFN-? binding fragments, derivatives and variants thereof. In addition, pharmaceutical compositions, kits, and methods for use in diagnosis and therapy are described.
    Type: Grant
    Filed: January 21, 2021
    Date of Patent: April 2, 2024
    Assignee: IMMUNOQURE AG
    Inventors: Syeda F. Y. Haque, Adrian Hayday, Kai Kisand, Kai Krohn, Annalisa Macagno, Steffen Meyer, Paert Peterson, Mike Rothe, Philip Vlaicu, Martin Woodward
  • HUMAN ANTI-IFN-ALPHA ANTIBODIES
    Publication number: 20210221883
    Abstract: Provided are novel IFB-a binding molecules of human origin, particularly human-derived anti-IFN-? antibodies as well as IFN-? binding fragments, derivatives and variants thereof. In addition, pharmaceutical compositions, kits, and methods for use in diagnosis and therapy are described.
    Type: Application
    Filed: January 21, 2021
    Publication date: July 22, 2021
    Inventors: Syeda F. Y. HAQUE, Adrian HAYDAY, Kai KISAND, Kai KROHN, Annalisa MACAGNO, Steffen MEYER, Paert PETERSON, Mike ROTHE, Philip VLAICU, Martin WOODWARD
  • CDNA encoding a monoclonal anti-IL-32 antibody and methods for the production of the antibody
    Patent number: 10975144
    Abstract: Provided are novel IL-32 binding molecules of human origin, particularly human anti-IL-32 antibodies as well as IL-32 binding fragments, derivatives and variants thereof. In addition, pharmaceutical compositions, kits and methods for use in diagnosis and therapy are described.
    Type: Grant
    Filed: August 21, 2018
    Date of Patent: April 13, 2021
    Assignee: ImmunoQure AG
    Inventors: Adrian Hayday, Kai Kisand, Kai Krohn, Annalisa Macagno, Shimobi Onuoha, Paert Peterson, Mike Rothe, Martin Woodward, Syeda F. Y. Haque
  • Human anti-IFN-? antibodies
    Patent number: 10941198
    Abstract: Provided are novel IFB-a binding molecules of human origin, particularly human-derived anti-IFN-? antibodies as well as IFN-? binding fragments, derivatives and variants thereof. In addition, pharmaceutical compositions, kits, and methods for use in diagnosis and therapy are described.
    Type: Grant
    Filed: September 17, 2018
    Date of Patent: March 9, 2021
    Inventors: Syeda F. Y. Haque, Adrian Hayday, Kai Kisand, Kai Krohn, Annalisa Macagno, Steffen Meyer, Paert Peterson, Mike Rothe, Philip Vlaicu, Martin Woodward
  • HUMAN ANTI-IL-32 ANTIBODIES
    Publication number: 20190112367
    Abstract: Provided are novel IL-32 binding molecules of human origin, particularly human anti-IL-32 antibodies as well as IL-32 binding fragments, derivatives and variants thereof. In addition, pharmaceutical compositions, kits and methods for use in diagnosis and therapy are described.
    Type: Application
    Filed: August 21, 2018
    Publication date: April 18, 2019
    Inventors: Adrian Hayday, Kai Kisand, Kai Krohn, Annalisa Macagno, Shimobi Onuoha, Paert Peterson, Mike Rothe, Martin Woodward, Syeda F. Y. Haque
  • HUMAN ANTI-IFN-ALPHA ANTIBODIES
    Publication number: 20190071499
    Abstract: Provided are novel IFB-a binding molecules of human origin, particularly human-derived anti-IFN-? antibodies as well as IFN-? binding fragments, derivatives and variants thereof. In addition, pharmaceutical compositions, kits, and methods for use in diagnosis and therapy are described.
    Type: Application
    Filed: September 17, 2018
    Publication date: March 7, 2019
    Inventors: Syeda F. Y. HAQUE, Adrian HAYDAY, Kai KISAND, Kai KROHN, Annalisa MACAGNO, Steffen MEYER, Paert PETERSON, Mike ROTHE, Philip VLAICU, Martin WOODWARD
  • Human anti-IFN-? antibodies
    Patent number: 10112995
    Abstract: Provided are novel IFB-a binding molecules of human origin, particularly human-derived anti-IFN-? antibodies as well as IFN-? binding fragments, derivatives and variants thereof. In addition, pharmaceutical compositions, kits, and methods for use in diagnosis and therapy are described.
    Type: Grant
    Filed: July 3, 2014
    Date of Patent: October 30, 2018
    Assignee: ImmunoQure AG
    Inventors: Syeda F. Y. Haque, Adrian Hayday, Kai Kisand, Kai Krohn, Annalisa Macagno, Steffen Meyer, Paert Peterson, Mike Rothe, Philip Vlaicu, Martin Woodward
  • Human anti-IL-32 antibodies and methods of making and using the same
    Patent number: 10081676
    Abstract: Provided are novel IL-32 binding molecules of human origin, particularly human anti-IL-32 antibodies as well as IL-32 binding fragments, derivatives and variants thereof. In addition, pharmaceutical compositions, kits and methods for use in diagnosis and therapy are described.
    Type: Grant
    Filed: July 3, 2014
    Date of Patent: September 25, 2018
    Assignee: ImmunoQure AG
    Inventors: Adrian Hayday, Kai Kisand, Kai Krohn, Annalisa Macagno, Shimobi Onuoha, Paert Peterson, Mike Rothe, Martin Woodward, Syeda F. Y. Haque
  • HUMAN ANTI-IFN-ALPHA ANTIBODIES
    Publication number: 20170051055
    Abstract: Provided are novel IFN-? binding molecules of human origin, particularly human-derived anti-IFN-? antibodies as well as IFN-? binding fragments, derivatives and variants thereof. In addition, pharmaceutical compositions, kits and methods for use in diagnosis and therapy are described.
    Type: Application
    Filed: July 3, 2014
    Publication date: February 23, 2017
    Inventors: Syeda F.Y. HAQUE, Adrian HAYDAY, Kai KISAND, Kai KROHN, Annalisa MACAGNO, Steffen MEYER, Paert PETERSON, Mike ROTHE, Philip VLAICU, Martin WOODWARD
  • HUMAN ANTI-IL-32 ANTIBODIES
    Publication number: 20160368981
    Abstract: Provided are novel IL-32 binding molecules of human origin, particularly human anti-IL-32 antibodies as well as IL-32 binding fragments, derivatives and variants thereof. In addition, pharmaceutical compositions, kits and methods for use in diagnosis and therapy are described.
    Type: Application
    Filed: July 3, 2014
    Publication date: December 22, 2016
    Inventors: Andrian HAYDAY, Kai KISAND, Kai KROHN, Annalisa MACAGNO, Shimobi ONUOHA, Paert PETERSON, Mike ROTHE, Martin WOODWARD, Syeda F.Y. HAQUE